AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzhou University; Nanfang Hospital, Southern Medical University; The Affiliated Hospital of Qingdao University; Ruijin Hospital; Sixth Affiliate d Hospital, Sun Yat-sen University; Peking Union Medical College Hospital; Xiangya Hospital of Central South University; Affiliated Cancer Hospital& Institute of Guangzhou Medical University; The First Affiliated Hospital of Soochow University; First Affiliated Hospital, Sun Yat-Sen University; Fujian Medical University Union Hospital; Fujian Cancer Hospital; San Raffaele University Hospital, Italy Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Academies | Cancer | Cancer & Oncology | Chemotherapy | China Health | Gastric (Stomach) Cancer | Gastroenterology | Hospitals | Italy Health | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pathology | Research